Rosuvastatin may stabilize vulnerable carotid plaques and reduce carotid intima media thickness in patients with hyperlipidemia. - Suppr | 超能文献

相似文献

1

Rosuvastatin may stabilize vulnerable carotid plaques and reduce carotid intima media thickness in patients with hyperlipidemia.

Int J Cardiol. 2016 Jun 1;212:20-1. doi: 10.1016/j.ijcard.2016.03.029. Epub 2016 Mar 16.

2

Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label).阿托伐他汀对杂合子家族性高胆固醇血症患儿颈动脉内膜中层厚度的影响：CHARON 研究（儿童和青少年服用阿托伐他汀开放性标签研究中的高胆固醇血症）。

Circulation. 2017 Jul 25;136(4):359-366. doi: 10.1161/CIRCULATIONAHA.116.025158. Epub 2017 Jun 7.

3

Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial.瑞舒伐他汀对低危个体颈总动脉内膜中层回声的影响：METEOR 试验。

J Am Soc Echocardiogr. 2012 Oct;25(10):1120-1127.e1. doi: 10.1016/j.echo.2012.07.004. Epub 2012 Aug 9.

4

Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study.与安慰剂相比，基线颈动脉内膜中层厚度是否会改变瑞舒伐他汀对颈动脉内膜中层厚度进展的影响？METEOR研究。

Eur J Cardiovasc Prev Rehabil. 2010 Apr;17(2):223-9. doi: 10.1097/HJR.0b013e3283359c38.

5

Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study.强化降脂治疗可能在治疗12个月内减缓颈动脉粥样硬化进展：METEOR研究

J Intern Med. 2009 Jun;265(6):698-707. doi: 10.1111/j.1365-2796.2009.02073.x. Epub 2009 Mar 2.

6

Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease.阿托伐他汀对无症状颈动脉疾病的高胆固醇血症患者 2 年治疗对内膜中层厚度的影响。

Expert Opin Pharmacother. 2011 Dec;12(17):2599-604. doi: 10.1517/14656566.2011.618497. Epub 2011 Oct 15.

7

Hyperlipidaemia presenting as palmoplantar pain.以掌跖疼痛为表现的高脂血症。

Australas J Dermatol. 2018 Aug;59(3):e213-e214. doi: 10.1111/ajd.12722. Epub 2017 Sep 19.

8

[Impact on the carotid intima-medial thickness and safety of rosuvastatin in Chinese patients with carotid atherosclerosis: a meta-analysis].瑞舒伐他汀对中国颈动脉粥样硬化患者颈动脉内膜中层厚度的影响及安全性：一项荟萃分析

Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Mar;42(3):247-53.

9

Short Communication: The Effect of Rosuvastatin on Vascular Disease Differs by Smoking Status in Treated HIV Infection.简短通讯：瑞舒伐他汀对接受治疗的HIV感染患者血管疾病的影响因吸烟状况而异。

AIDS Res Hum Retroviruses. 2018 Mar;34(3):282-285. doi: 10.1089/AID.2017.0164. Epub 2017 Nov 17.

10

Treatment with telmisartan/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis.替米沙坦/瑞舒伐他汀联合治疗对改善高血压合并颈动脉粥样硬化患者 Th17/Treg 功能失衡具有有益的协同作用。

Atherosclerosis. 2014 Mar;233(1):291-9. doi: 10.1016/j.atherosclerosis.2013.12.004. Epub 2014 Jan 10.

引用本文的文献

1

Relationship between Atherogenic Indices and Carotid Intima-Media Thickness in Prediabetes: A Cross-Sectional Study from Central India.糖尿病前期人群动脉粥样硬化指数与颈动脉内膜中层厚度的关系：一项来自印度中部的横断面研究。

Med Sci (Basel). 2018 Jul 5;6(3):55. doi: 10.3390/medsci6030055.